Neuren Pharmaceuticals Product Pipeline Review 2012

Neuren Pharmaceuticals Product Pipeline Review 2012 provides data on the Neuren Pharmaceuticals Limited’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- Neuren Pharmaceuticals Limited - Brief Neuren Pharmaceuticals Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Neuren Pharmaceuticals Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Neuren Pharmaceuticals Limited with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Neuren Pharmaceuticals Limited’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Neuren Pharmaceuticals Limited’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Neuren Pharmaceuticals Limited in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Neuren Pharmaceuticals Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Neuren Pharmaceuticals Limited.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Neuren Pharmaceuticals Limited and identify potential opportunities in those areas.

Keyword

Current R&D Portfolio of Neuren Pharmaceuticals Limited; Neuren Pharmaceuticals Limited - Key Therapeutics; Neuren Pharmaceuticals Limited - Pipeline Overview and Promising Molecules; Neuren Pharmaceuticals Limited - News; Neuren Pharmaceuticals Limited - Latest Updates; Neuren Pharmaceuticals Limited - Pipeline; Neuren Pharmaceuticals Limited - Discontinued/Dormant Projects

To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/67548/neuren-pharmaceuticals-limited-product-pipeline-review-2012.html